OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Commerce. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
Click here to read the articles and download the PDF
Creating positive experiences and other patient-focused strategies for sponsors to consider when planning and executing cancer studies
Not quite specialty, not quite retail: Cost-effective access and support strategies for a growing, yet underserved, treatment market
The patient-first, pharmacy-first hub model optimizes outcomes and improves care journey for patients with rare disease
May 20, 2022
How do manufacturers balance logistical demands and environmental impact?
May 19, 2022
East Syracuse site will serve as a hub for company’s US biologics CDMO business
May 18, 2022
Should be administered at least five months after the second dose of the two-dose primary series
Leveraging the value healthcare professionals place on scientific content
Deal establishes company’s presence in Mexico
May 17, 2022
For pharma companies, an investment in a digital risk management tool is worth considering if they want to meet the European Union's regulatory requirements for pharmaceutical transport and wholesalers
It is the first solution that allows pharma and biotech to design, set up, plan, orchestrate, and scale APT supply chains with one single system, the company reports
May 16, 2022
Will be investing up to $100 million to expand presence in Taiwan
With a $1 billion public commitment, diverse talent and science, space, and VC funding, NYC is emerging as a global capital of life sciences
May 13, 2022
Biopharma firm strives to deliver savings to the US healthcare system